Form 4: Savara Director David Ramsay Boosts Stake with RSU Grant

Savara Inc. Director David A. Ramsay acquired 40,000 restricted stock units, increasing his beneficial ownership to over 2.5 million shares.

Summary

• David A. Ramsay, a Director of Savara Inc. (SVRA), acquired 40,000 restricted stock units (RSUs) on December 9, 2025.
• The RSUs were granted at a price of $0.00 per unit.
• Each RSU represents a contingent right to receive one share of Savara Inc.'s common stock.
• The RSUs are scheduled to vest in full on December 9, 2026, contingent upon Mr. Ramsay's continued service with the Issuer.
• Following this transaction, Mr. Ramsay beneficially owns 2,553,642 shares of Savara Inc. common stock.
• The transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 7

Explanation: The grant of restricted stock units to a director is generally a positive indicator, as it aligns the director's interests with shareholders and is a routine compensation event. It does not, however, provide significant new operational or financial information to warrant a higher score.

Positives

• The acquisition of 40,000 restricted stock units by a Director indicates continued alignment of management's interests with those of shareholders.
• The transaction was executed under a Rule 10b5-1 plan, which promotes transparency and reduces the perception of opportunistic insider trading.

Risks

• The vesting of the 40,000 restricted stock units is subject to the reporting person's continued service with Savara Inc. until December 9, 2026.

Future Outlook

The acquired restricted stock units are scheduled to vest in full on December 9, 2026, contingent on the director's continued service with Savara Inc.

Industry Context

The grant of restricted stock units to a director is a common form of equity compensation in the biotechnology and pharmaceutical industry, aligning executive incentives with long-term shareholder value creation. The use of a Rule 10b5-1 plan for such transactions is also standard practice for managing insider trading compliance.

Comparison to Industry Standards

• Equity grants to directors, such as the 40,000 RSUs to David Ramsay, are a standard component of compensation packages across publicly traded companies, particularly in growth-oriented sectors like biotech. This practice is consistent with global benchmarks for executive and director remuneration, aiming to align leadership interests with long-term company performance.
• The use of Rule 10b5-1 plans for insider transactions is a widely adopted best practice among U.S. public companies, including peers of Savara Inc., to provide an affirmative defense against insider trading allegations and enhance transparency around planned stock transactions.

Corporate Governance

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's financial interests with long-term shareholder value, as the value of the RSUs is tied to the company's stock performance.
• Employees: No direct impact on general employees is indicated by this filing.

Next Steps

• The 40,000 restricted stock units are expected to vest on December 9, 2026, subject to the director's continued service.

Key Dates

Keywords

Savara Inc, SVRA, Form 4, Insider Transaction, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Beneficial Ownership, Rule 10b5-1